• ERT and Bioclinica are now Clario. Find out more about our new name, and why we have come together.

Your using an unsupported browser. Please update to a modern browser for a better experience.

From clinical care to clinical trials: The importance of proper clinic BP assessment methods

Clario

Jeff Heilbraun, MS – Vice President, Medical and Scientific Affairs, Cardiology at ClarioDr. Todd Rudo – Chief Medical Officer at Clario Awareness of one’s blood pressure (BP) is critical for cardiovascular health and overall well-being. There’s overwhelming evidence that untreated high blood pressure (hypertension) is associated with adverse consequences such as stroke, heart attack, kidney […]

Read More… from From clinical care to clinical trials: The importance of proper clinic BP assessment methods

Total metabolic tumor volume — A valuable new method of assessment of global response to therapy

Clario

John G Wolodzko, PhD, DABSNM, FACNM – Sr. Medical Physicist at Clario Over the past few years, many papers have been published by groups investigating the utility of 18F-fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) for screening and therapy response assessment in various lymphoma subtypes. Several of these studies have reported the value of total metabolic tumor volume […]

Read More… from Total metabolic tumor volume — A valuable new method of assessment of global response to therapy

Future strategies in software quality engineering

Clario

Preeti Puppala – Manager, Software Quality Engineering (V&V) Validation Verification  Quality is of critical importance in the Software Technology industry. In addition to regular testing practices, organizations should monitor data collection and analytics by embedding quality checks into software testing and digitalization. Embedding quality into everyday practices promotes regular data checks that make organizations more […]

Read More… from Future strategies in software quality engineering

Immunizations: Protecting the world from the ravages of disease

Clario

Robert Kleiman, MD – VP, Cardiology & Chief Medical Officer at Clario  August is National Immunization Awareness Month (NIAM), a month dedicated to highlighting the importance of vaccinations for all ages. Clario recognizes the success of immunizations, including the more than 100 vaccines it has helped to develop in its 50-year history.  Vaccinations have effectively […]

Read More… from Immunizations: Protecting the world from the ravages of disease

New opinions and trends in oncology PROs: Learnings from the 2022 FDA COA in cancer trials workshop

Clario

Kelly Dumais, PhD – Principal Scientific Advisor at ClarioJowita Marszewska, PhD – Scientific Advisor at Clario The FDA’s Oncology Center of Excellence (OCE) conducts annual public workshops on clinical outcome assessments (COAs) in cancer clinical trials. These workshops bring top leaders (and importantly, patient advocates) together for interactive conversations that seek to answer our most […]

Read More… from New opinions and trends in oncology PROs: Learnings from the 2022 FDA COA in cancer trials workshop

Clario finds patients are as compliant at home as on-site

Clario

Kelly Dumais, PhD – Senior Scientific Advisor  Our research shows that oncology clinical trial patients are just as compliant when completing patient-reported outcomes (PROs) at home as they are when completing PROs on-site. These findings demonstrate that at-home PRO completion is a viable method for oncology clinical trials, which we believe will help accommodate the […]

Read More… from Clario finds patients are as compliant at home as on-site

FDA draft guidance blood pressure monitoring in clinical trials – questions answered

Jeff Heilbraun, MS – VP Medical Affairs, Cardiac Safety Within the clinical trials arena, there are many references of blood pressure monitoring in protocols across all study phases and therapeutic indications. Blood pressure is often associated within a study’s schedule of events as a standard vital sign or safety assessment. Specific to the development of […]

Read More… from FDA draft guidance blood pressure monitoring in clinical trials – questions answered

Creating hope, improving lives

Expressing gratitude for those who contribute to clinical research every day Lynne Borthwick – EVP and Chief People Officer at Clario Today is International Clinical Trials Day. For many people reading this, I’d guess this is news to you. For my colleagues at Clario and me, this is an important day because it celebrates the anniversary […]

Read More… from Creating hope, improving lives

eDiaries: How often is too often?

Valdo Arnera, MD – eCOA Scientific Advisor Clario began using e-diaries in clinical trials nearly 25 years ago. During this time, two fundamentalquestions have continued to arise: How often should a questionnaire be completed by the patient? That is, how much can we reasonably ask of a patient daily? What about weekly or monthly? Too […]

Read More… from eDiaries: How often is too often?

World Earth Day: Sharing our sustainability initiatives and joining the UN Global Compact 

Dr. Otis Johnson – Chief Diversity, Inclusion and Sustainability Officer at Clario Clinical trials save lives, so it’s easy to see the good that Clario’s work does simply in terms of the nature of the industry in which we operate. However, I see a broader responsibility for companies such as Clario. As a leader in our […]

Read More… from World Earth Day: Sharing our sustainability initiatives and joining the UN Global Compact